1. (1) All in-patient investigational drugs must be stored in the pharmacy and may only be distributed from the pharmacy when properly labeled.
2. (2) Information concerning the dosage form, route of administration, strength, actions, uses, side effects, adverse effects, interactions and symptoms of toxicity of such drugs must be available in the pharmacy.
3. (3) Investigational drugs may only be ordered by a designated physician-investigator or their authorized clinician, subject to the prior approval of the appropriate hospital committee.
4. (4) Each order must include the appropriate protocol number.

Statutory/Other Authority

ORS 689.205

Statutes/Other Implemented

ORS 689.155

History

BP 3-2010, f. 4-29-10, cert. ef. 4-30-10